First City Capital Management’s Celgene Corp CELG Stock Holding History

First City Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-60	Closed	-$6K	–	642
2016 Q1	$6K	Hold	60	–	–	﹤0.01%	522
2015 Q4	$7.19K	Hold	60	–	–	﹤0.01%	508
2015 Q3	$6.49K	Buy	+60	New	+$7.45K	﹤0.01%	488

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

First City Capital Management's CELG Position: Q2 2016 in Review

First City Capital Management sold out of Celgene Corp (CELG) in Q2 2016, closing a stake of 60 shares — an estimated $6K sold.

First City Capital Management first reported a position in CELG in Q3 2015 and held it in 3 quarters. The position peaked at $7.19K in Q4 2015. 1,218 funds tracked by Wall St. Rank hold CELG as of Q2 2016.

First City Capital Management reported no remaining Celgene Corp position as of Q2 2016 after selling out during the quarter.
First City Capital Management sold 60 Celgene Corp shares in Q2 2016, an estimated $6K.
First City Capital Management first reported a position in Celgene Corp in Q3 2015 and held it in 3 quarters.
First City Capital Management's Celgene Corp position peaked at $7.19K in Q4 2015.
1,218 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2016.

Based on First City Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.